BACKGROUND & AIMS: Irritable bowel syndrome
(IBS) has been associated with disruptions to the intestinal
microbiota, but studies have had limited power, coverage,
and depth of analysis. We aimed to define microbial
populations that can be used discriminate the fecal microbiota
of patients with IBS from that of healthy subjects
and correlate these with IBS intestinal symptom scores